- Home
- PED vs CTSO Comparison
PED vs CTSO Comparison
Compare PED & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- CTSO
- Stock Information
- Founded
- PED N/A
- CTSO 1997
- Country
- PED United States
- CTSO United States
- Employees
- PED N/A
- CTSO N/A
- Industry
- PED Oil & Gas Production
- CTSO Medical/Dental Instruments
- Sector
- PED Energy
- CTSO Health Care
- Exchange
- PED Nasdaq
- CTSO Nasdaq
- Market Cap
- PED 48.8M
- CTSO 52.6M
- IPO Year
- PED N/A
- CTSO N/A
- Fundamental
- Price
- PED $0.64
- CTSO $1.09
- Analyst Decision
- PED Strong Buy
- CTSO Buy
- Analyst Count
- PED 2
- CTSO 2
- Target Price
- PED $1.63
- CTSO $5.50
- AVG Volume (30 Days)
- PED 596.3K
- CTSO 134.5K
- Earning Date
- PED 08-13-2025
- CTSO 08-12-2025
- Dividend Yield
- PED N/A
- CTSO N/A
- EPS Growth
- PED 2248.88
- CTSO N/A
- EPS
- PED 0.19
- CTSO N/A
- Revenue
- PED $40,173,000.00
- CTSO $35,332,238.00
- Revenue This Year
- PED N/A
- CTSO $18.34
- Revenue Next Year
- PED $5.99
- CTSO $19.82
- P/E Ratio
- PED $3.27
- CTSO N/A
- Revenue Growth
- PED 30.70
- CTSO 15.37
- 52 Week Low
- PED $0.47
- CTSO $0.71
- 52 Week High
- PED $1.10
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- PED 44.05
- CTSO 50.63
- Support Level
- PED $0.58
- CTSO $0.93
- Resistance Level
- PED $0.67
- CTSO $1.16
- Average True Range (ATR)
- PED 0.04
- CTSO 0.11
- MACD
- PED -0.01
- CTSO -0.02
- Stochastic Oscillator
- PED 21.96
- CTSO 38.18
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.